Specialized M&A guidance for licensed rehab facilities, IOP programs, and residential treatment centers in the $1M–$5M revenue range.
Find Addiction Treatment Center Deals Without a BrokerThe U.S. addiction treatment market exceeds $42 billion and remains highly fragmented, creating strong acquisition opportunities. Sellers typically exit at 4–7x EBITDA. A broker with behavioral health experience navigates CARF accreditation, payor contracts, and compliance exposure that generalist advisors routinely miss.
Boutique advisors focused exclusively on behavioral health and addiction treatment transactions. Deep knowledge of licensing, payor mix, and accreditation due diligence.
Best for: Sellers with CARF-accredited facilities, commercial insurance contracts, or PE buyer interest seeking maximum valuation.
Generalist healthcare brokers handling medical practices, home health, and behavioral health. Broader buyer networks but less addiction-specific regulatory expertise.
Best for: Smaller outpatient IOP programs under $2M revenue where a specialist retainer may not be cost-justified.
Investment bankers handling $2M–$10M EBITDA deals across industries including healthcare. Best positioned for PE-backed roll-up transactions requiring formal process management.
Best for: Multi-site operators or sellers targeting private equity behavioral health platforms with competitive auction processes.
Skip the broker — find deals direct
DealFlow OS surfaces off-market Addiction Treatment Center targets with seller signals and outreach angles. No commission.
How many addiction treatment or behavioral health facilities have you sold in the last three years, and what were the typical EBITDA multiples achieved?
Closed deal experience in this specific sector confirms the broker understands payor mix, accreditation, and compliance factors that directly drive valuation.
How do you handle buyer due diligence on billing compliance, RAC audit history, and Medicaid credentialing during the transaction?
Compliance exposure is the most common deal-killer in addiction treatment acquisitions; a specialist broker must manage this proactively to protect closing.
What is your buyer network composition — individual operators, PE platforms, or hospital systems — and how do you qualify behavioral health buyers?
Payor mix and licensing complexity require buyers with healthcare operating experience; unqualified buyers waste time and expose confidential information.
How do you value intangible assets like referral relationships, alumni networks, and clinical reputation in your pricing recommendation?
These assets represent significant enterprise value in addiction treatment but require sector-specific methodology that generalist brokers often undervalue.
Most accredited facilities with diversified payor mix sell at 4–7x EBITDA. Strong commercial insurance contracts, tenured clinical staff, and clean compliance history push multiples toward the higher end.
Yes. SBA 7(a) loans are commonly used, covering 80–90% of purchase price. Buyers need clean licensing, active accreditation, and a seller willing to provide a short transition period.
Most transactions close within 12–24 months from initial preparation. Sellers who complete accreditation renewal, internal billing audits, and financial clean-up before listing close significantly faster.
Billing compliance gaps, Medicaid-only payor concentration, expiring facility leases, and founder dependency without succession planning are the four most frequent deal-breakers experienced buyers identify.
More Addiction Treatment Center Guides
Find Brokers in Other Industries
DealFlow OS surfaces off-market targets, scores seller motivation, and writes your outreach. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers